GU Cancers 2020 | Genomic prognostics for prostate cancer salvage radiotherapy

Name: Genomic prognostics for prostate cancer salvage radiotherapy
Uploaded: 2020-02-13T00:00:00.000Z
Duration: 2 min 10 s
Description: Bridget Koontz, MD, Duke University Medical Center, Durham, NC, discusses the validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Bridget Koontz • 13 Feb 2020

GU Cancers 2020

Genitourinary Cancer Prostate Cancer

Bridget Koontz, MD, Duke University Medical Center, Durham, NC, discusses the validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.